The New European Industrial Policy and the Case of the ‘Pharmaceuticals and Biotechnology’ Industry

Franco Mosconi ()
Additional contact information
Franco Mosconi: University of Parma

A chapter in Economic Challenges for Europe After the Pandemic, 2022, pp 43-57 from Springer

Abstract: Abstract During the first two decades of the twenty-first century, industrial policy regained progressively its prominence on the European scene. But what kind of policy are we talking about? This paper tries to answer this question by looking at the approach that the EU—and, in particular, the European Commission—developed between 2002 and 2021. In this context, the EU’s ‘new’ industrial policy is one in which a central position is occupied by the increase of knowledge-based investments and the development of enabling technologies; these two priorities have become quite critical now that manufacturing has made a come-back and is reclaiming its vital role in advancing vibrant economic growth.

Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:prbchp:978-3-031-10302-5_4

Ordering information: This item can be ordered from
http://www.springer.com/9783031103025

DOI: 10.1007/978-3-031-10302-5_4

Access Statistics for this chapter

More chapters in Springer Proceedings in Business and Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().